mycophenolate sodium: Clinical Trials

5 trials of mycophenolate sodium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Recruiting 1, Terminated 1
Phase 21Recruiting 1

Follow mycophenolate sodium: new trials by email Literature Review of mycophenolate sodium trials Research Report on mycophenolate sodium

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
Frexalimab, Tacrolimus, rabbit anti-thymocyte globulin - Kidney Transplant Rejection
Phase 2 / Phase 3RecruitingSanofi5262026-03-132026-10-13
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
Everolimus, Tacrolimus, Mycophenolate sodium - Chronic Kidney Disease
Phase 3CompletedPoitiers University Hospital3292014-12-112021-01-29
Everolimus in de Novo Kidney Transplant Recipients
Everolimus, Mycophenolate sodium, Cyclosporine - Kidney Transplantation
Phase 3CompletedNovartis Pharmaceuticals3832011-11-012017-06-16
Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Myfortic, Decortin - Uveitis, Intermediate
Phase 3CompletedSTZ eyetrial442010-03-012017-05-09
The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
mycophenolate sodium, cyclophosphamide - Lupus Nephritis
Phase 3TerminatedChulalongkorn University592010-01-012014-10-10

Conditions studied

Lupus Nephritis (1)  ·  Renal Insufficiency, Chronic (1)  ·  Uveitis, Intermediate (1)

Sponsors

Chulalongkorn University (1)  ·  Novartis Pharmaceuticals (1)  ·  Poitiers University Hospital (1)  ·  STZ eyetrial (1)  ·  Sanofi (1)

Countries

France (2)  ·  Italy (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Chile (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Netherlands (1)

Top investigators

Christoph Deuter, Dr. (1)  ·  Yingyos Avihingsanon, MD (1)

Results publications

PMID 26835147

NIH funding

2009 (1), 2025 (1)